ACTIVE BIOTECH AB

Insiders Active Biotech AB London S.E.

Equities

0GQU

SE0001137985

Market Closed - London S.E. Other stock markets 09:57:30 2021-02-02 am EST			5-day change	1st Jan Change
1.52 ^SEK	-8.13%		+50.02%	+50.02%

Jul. 01	Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis	CI
May. 22	Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Active Biotech AB Appoints Mats Arnhög and Petter Wingstrand to Nomination Committee	Dec. 01	CI
Active Biotech's Announces Nomination Committee	22-12-05	CI
Active Biotech AB Appoints Erik Vahtola as Chief Medical Officer	22-01-04	CI
Active Biotech AB Appoints Elaine Sullivan as A Director	20-11-25	CI
Active Biotech AB Announces Board Changes	20-05-19	CI
Active Biotech AB Announces Board Appointments	19-05-23	CI
Active Biotech : election committee appointed	18-11-19	GL
Active Biotech AB Appoints Election Committee Members	18-11-19	CI
Active Biotech : election committee appointed	17-11-17	GL
Active Biotech AB Announces Executive Changes	17-06-19	CI
Active Biotech : election committee appointed	16-11-22	GL
Active Biotech : election committee appointed	15-11-23	GL
Active Biotech Appoints Members of Election Committee	15-11-23	CI
Active Biotech : election committee appointed	14-12-09	GL
Active Biotech AB : Active Biotech's election committee appointed	13-11-11	PU
Active Biotech AB Appoints Election Committee for the 2014 AGM	13-11-11	CI
Active Biotech AB Elects Rolf Kiessling as Board Member	13-05-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer